+135.0%
GSK vs BR
+1,450.0%
-1,315.0%
-49.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | BR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.3% | -3.4% | +1.1% | -1.3% |
| 7D | -3.0% | -2.3% | -0.7% | -2.3% |
| 30D | +0.4% | +7.7% | -7.3% | -1.9% |
| 3M | -1.2% | +13.0% | -14.2% | -4.9% |
| 6M | +0.9% | +31.2% | -30.3% | -7.6% |
| YTD | +4.0% | -13.9% | +17.9% | +7.6% |
| 1Y | +7.3% | -14.2% | +21.5% | +11.1% |
| 3Y | +57.1% | +9.0% | +48.1% | +48.7% |
| 5Y | +43.0% | +18.2% | +24.8% | +29.6% |
| 10Y | +103.1% | +246.2% | -143.2% | +23.9% |
| All | +135.0% | +1,450.0% | -1,315.0% | -17.2% |
Cumulative growth
Daily Returns
Daily percentage return beside BR.
Daily Out/Under-Performance
Portfolio return minus BR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded BR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling